97 related articles for article (PubMed ID: 2081201)
1. Kinetics of intravenously administered carnitine in haemodialysed children.
Glöggler A; Bulla M; Fürst P
J Pharm Biomed Anal; 1990; 8(5):411-4. PubMed ID: 2081201
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
3. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.
Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
J Pharm Sci; 1995 May; 84(5):634-9. PubMed ID: 7658357
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
6. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
Glöggler A; Bulla M; Fürst P
Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of L-carnitine.
Evans AM; Fornasini G
Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units.
Müller C; Kremer W; Harlfinger S; Doroshyenko O; Jetter A; Hering F; Hünseler C; Roth B; Theisohn M
Eur J Pediatr; 2006 Apr; 165(4):229-39. PubMed ID: 16496200
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
Fornasini G; Upton RN; Evans AM
Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
[TBL] [Abstract][Full Text] [Related]
14. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
Yokogawa K; Higashi Y; Tamai I; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Miyamoto K; Tsuji A
J Pharmacol Exp Ther; 1999 Apr; 289(1):224-30. PubMed ID: 10087008
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenously administered glutathione in the rat.
Ammon HP; Melien MC; Verspohl EJ
J Pharm Pharmacol; 1986 Oct; 38(10):721-5. PubMed ID: 2878990
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients.
Garg DC; Baltodano N; Perez GO; Oster JR; Jallad NS; Weidler DJ
Pharmacology; 1985; 31(4):189-93. PubMed ID: 4059323
[TBL] [Abstract][Full Text] [Related]
17. The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis.
Yderstraede KB; Pedersen FB; Dragsholt C; Trostmann A; Laier E; Larsen HF
Nephrol Dial Transplant; 1987; 1(4):238-41. PubMed ID: 3110681
[TBL] [Abstract][Full Text] [Related]
18. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
Brass EP; Adler S; Sietsema KE; Hiatt WR; Orlando AM; Amato A;
Am J Kidney Dis; 2001 May; 37(5):1018-28. PubMed ID: 11325685
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and organ distribution of liposome-encapsulated L-carnitine in rats.
Jäger W; Koch HP
Arzneimittelforschung; 1993 Sep; 43(9):974-7. PubMed ID: 8240461
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefonicid in uraemic patients.
Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
